KORONAVIRUS INFEKSIYASI COVID-19 BILAN KASALLANGAN BOLALARDA TIZIMLI VASKULITNING KLINIK VA IMMUNOLOGIK XUSUSIYATLARI
Article Sidebar
Main Article Content
Abstract
The study was conducted prospectively from 2023 to 2026 at the Clinic of Tashkent State University and the Republican Specialized Scientific and Practical Center of Pediatrics. A total of 50 children were included: 30 had COVID-19, and 20 had not.
The children underwent clinical monitoring, laboratory, and immunological examinations, including complete blood count, CRP, ESR, Interleukin-6, ANA, D-dimer, echocardiography (ECHO), electrocardiography (ECG), and abdominal ultrasound. The results showed that children who had COVID-19 experienced more severe systemic vasculitis, with higher inflammatory and immunological activity, and more frequent complications. These findings highlight the need for thorough clinical and immunological monitoring of such patients.
Article Details
Section
References
1. World Health Organization. (2020). Coronavirus disease (COVID-19) pandemic. Geneva: WHO.
2. Gupta, A., Madhavan, M.V., Sehgal, K., et al. (2020). Extrapulmonary manifestations of COVID-19. Nature Medicine, 26, 1017–1032.
3. Varga, Z., Flammer, A.J., Steiger, P., et al. (2020). Endothelial cell infection and endotheliitis in COVID-19. The Lancet, 395(10234), 1417–1418.
4. Ludvigsson, J.F. (2020). Children are unlikely to be the main drivers of the COVID-19 pandemic – a systematic review. Acta Paediatrica, 109(8), 1525–1530.
5. Whittaker, E., Bamford, A., Kenny, J., et al. (2020). Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA, 324(3), 259–269.
6. Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423.
7. Hoffmann, M., Kleine-Weber, H., Schroeder, S., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8.